Abstract:Objectives Human embryonic stem cells (hESCs) serve as an attractive cell source for generating functional blood cells and hold great potential for cell-based therapy in future clinical applications. However, the underlying molecular mechanisms that regulate hESC differentiation into hematopoietic cells remain elusive. Therefore, understanding hESC differentiation is essential for the acquisition of sufficient and functional cells in vitro for successful clinical translation. Materials and Methods ELTD1 was identified as a potential mediator of hESC hematopoietic differentiation by genome-wide gene profiling. ELTD1-deleted human embryonic stem cell (hESC) lines were constructed by the iCRISPR/Cas9 technology and were used to undergo hematopoietic differentiation. Flow cytometry, quantitative RT-PCR, immunofluorescence, and RNA sequencing were used for phenotype and molecular mechanism assessment. Results Real-time PCR analysis and bioinformatic studies demonstrated that the dynamic expression of ELTD1 parallels the hemogenic endothelial progenitors-related genes expression and subsequently decreased as they differentiate into hematopoietic cells ( Figure A, C), leading us to speculate that it might play a role in hESC early hematopoietic differentiation. To further confirm these results, stage-specific cell populations at different time points were sorted to document the cell-type specificity of ELTD1. As shown in Figure B, ELTD1 was exclusively expressed in CD31 +CD34 + HEP populations. Loss-of-function studies revealed that ELTD1 deletion promoting the induction of CD31 +CD34 + HEPs at day 6, thereby promoting endothelial-to-hematopoietic transition to generate more CD43 +/CD45 + hematopoietic cells, and the results were confirmed by flow cytometry and immunofluorescence analyses ( Figure D, E and F). To dissect the molecular mechanism by which ELTD1 regulates hESC hematopoietic differentiation, the differentiated cells at day 6 were used to perform the RNA-Seq. KEGG analysis showed that hematopoietic cell lineage-related genes and Wnt signaling pathway were prominently enriched in ELTD1-deleted cells compared to WT-H1, consistent with the enhancement of HEPs and hematopoietic cells generation caused by ELTD1 deletion ( Figure G). Moreover, decreased expression of Wnt target genes: SOX17, TCF7L1, MYC, CCND1, BIRC5, and AXIN2 was further validated by quantitative RT-PCR analysis ( Figure H). To determine whether the downregulation of Wnt/β-catenin signaling is required for ELTD1 deletion-mediated enhancement of early hematopoietic differentiation from hESCs, we treated ELTD1-KO1# and ELTD1-KO2# hESCs with the Wnt agonist CHIR99021. As expected, treatment with CHIR99021 inhibited the generation of CD31 +CD34 + HEPs compared to ELTD1 deleted alone at day 6, which was validated by flow cytometry ( Figure I). Conclusions We identified ELTD1 as a novel regulator of hematopoietic differentiation, which may act via Wnt/β-catenin signaling, and provided new insights into understanding the mechanism of human hematopoiesis.

Overexpression of GATA2 Enhances Development and Maintenance of Human Embryonic Stem Cell-Derived Hematopoietic Stem Cell-like Progenitors

GATA2 −/− human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitment

Dynamic Regulation of GATA2 in Fate Determination in Hematopoiesis: Possible Approach to Hpsc-Derived Hematopoietic Stem/progenitor Cells

Generation and Analysis of GATA2w/eGFP Human ESCs Reveal ITGB3/CD61 as a Reliable Marker for Defining Hemogenic Endothelial Cells during Hematopoiesis.

Generation and Analysis of Gata2w/Egfp Human Escs Reveal Itgb3/Cd61 As A Reliable Marker for Defining Hemogenic Endothelial Cells During Hematopoiesis

MSX2 Suppression Through Inhibition of TGFβ Signaling Enhances Hematopoietic Differentiation of Human Embryonic Stem Cells.

[Effect of GATA-2 Overexpression on Function of Mouse Fetal Liver Hematopoietic Stem Cells].

Gata2 +9.5 Enhancer Regulates Adult Hematopoietic Stem Cell Self-Renewal and T-cell Development.

GATA-2 Regulates Granulocyte-Macrophage Progenitor Cell Function.

ELTD1 Suppression Enhances Human Embryonic Stem Cell Hematopoiesis by Facilitating Hemogenic Endothelial Progenitor Induction Via Wnt/β-Catenin Signaling Inhibition

Transcriptional Regulatory Network Controlling the Ontogeny of Hematopoietic Stem Cells

Characterization and generation of human definitive multipotent hematopoietic stem/progenitor cells

Co-Expression of Runx1, Hoxa9, Hlf, and Hoxa7 Confers Multi-Lineage Potential on Hematopoietic Progenitors Derived From Pluripotent Stem Cells

Multidimensional profiling reveals GATA1-modulated stage-specific chromatin states and functional associations during human erythropoiesis

TGFβ inhibition enhances the generation of hematopoietic progenitors from human ES cell-derived hemogenic endothelial cells using a stepwise strategy

A Conserved Role of Shp2 in Regulation of Human and Mouse Es Cell Differentiation

Long noncoding RNA GATA2AS influences human erythropoiesis by transcription factor and chromatin landscape regulation

Embryonic endothelial evolution towards first hematopoietic stem cells revealed by single-cell transcriptomic and functional analyses

Β-Catenin Coordinates with Jup and the TCF1/GATA6 Axis to Regulate Human Embryonic Stem Cell Fate

Derivation of Hematopoietic Stem Cells from Embryonic Stem Cells

Single-Cell Transcriptome of Early Hematopoiesis Guides Arterial Endothelium-Promoted Functional T Cell Generation from Human Pluripotent Stem Cells